@prefix	rdfs:	<http://www.w3.org/2000/01/rdf-schema#>	.
@prefix	local:	<http://local/local.owl#>	.
@prefix	ncit:	<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#>	.
@prefix	rdf:	<http://www.w3.org/1999/02/22-rdf-syntax-ns#>	.
@prefix	owl:	<http://www.w3.org/2002/07/owl#>	.

#### Statements ####

local:s46.1	a	rdf:Statement	;
	rdfs:label	"increasing hemorrhage"	.

local:s46	a	rdf:Statement	;
	rdfs:label	"longterm dual antiplatelet therapy started 8 to 14 days after onset was more effective for secondary stroke prevention than monotherapy without increasing hemorrhage risk"	.

local:s45.2	a	rdf:Statement	;
	rdfs:label	"15 to 180 days after stroke onset compared to therapy"	.

local:s45.1	a	rdf:Statement	;
	rdfs:label	"longterm dual antiplatelet therapy using cilostazol starting 15 to 180 days after stroke onset compared to therapy"	.

local:s45	a	rdf:Statement	;
	rdfs:label	"longterm dual antiplatelet therapy using cilostazol"	.

local:s44	a	rdf:Statement	;
	rdfs:label	"severe bleeding occurred similarly between patients on dual therapy in any of the trichotomized groups"	.

local:s43.1	a	rdf:Statement	;
	rdfs:label	"lifethreatening bleeding occurred similarly between patients on dual therapy in any of the trichotomized groups"	.

local:s43	a	rdf:Statement	;
	rdfs:label	"lifethreatening bleeding"	.

local:s42.1	a	rdf:Statement	;
	rdfs:label	"lifethreatening bleeding occurred similarly between those on monotherapy in any of the trichotomized groups"	.

local:s42	a	rdf:Statement	;
	rdfs:label	"lifethreatening bleeding"	.

local:s41	a	rdf:Statement	;
	rdfs:label	"severe bleeding occurred similarly between those on monotherapy in any of the trichotomized groups"	.

local:s35	a	rdf:Statement	;
	rdfs:label	"1879 patients 498 belonged to the 8 to 14 days group to 914 to the 29 to 180 days group"	.

local:s34	a	rdf:Statement	;
	rdfs:label	"1879 patients 498 belonged to 467 to the 15 to 28 days group"	.

local:s33	a	rdf:Statement	;
	rdfs:label	"1879 patients 498 belonged to 467 to 914 to the 29 to 180 days group"	.

local:s32	a	rdf:Statement	;
	rdfs:label	"1879 patients 498 belonged to the 8 to 14 days group to the 15 to 28 days group"	.

local:s31	a	rdf:Statement	;
	rdfs:label	"safety outcomes included severe bleeding"	.

local:s30	a	rdf:Statement	;
	rdfs:label	"safety outcomes included lifethreatening bleeding"	.

local:s16.1	a	rdf:Statement	;
	rdfs:label	"starting trial treatment"	.

local:s16	a	rdf:Statement	;
	rdfs:label	"patients between 8 days after stroke onset divided into 3 groups according to the timing of starting trial treatment"	.

local:s15.1	a	rdf:Statement	;
	rdfs:label	"starting trial treatment"	.

local:s15	a	rdf:Statement	;
	rdfs:label	"patients between 180 days after stroke onset divided into 3 groups according to the timing of starting trial treatment"	.

local:s13.1	a	rdf:Statement	;
	rdfs:label	"a subanalysis of the patients between 180 days after stroke onset receive clopidogrel alone"	.

local:s13	a	rdf:Statement	;
	rdfs:label	"in a subanalysis of the patients between 180 days after stroke onset randomly assigned to receive clopidogrel alone"	.

local:s11.1	a	rdf:Statement	;
	rdfs:label	"a subanalysis of the patients between 180 days after stroke onset receive aspirin"	.

local:s11	a	rdf:Statement	;
	rdfs:label	"in a subanalysis of the patients between 180 days after stroke onset randomly assigned to receive aspirin"	.

local:s9	a	rdf:Statement	;
	rdfs:label	"randomized controlled trial"	.

local:s7.1	a	rdf:Statement	;
	rdfs:label	"a subanalysis of the patients between 8 days after stroke onset receive aspirin"	.

local:s7	a	rdf:Statement	;
	rdfs:label	"in a subanalysis of the patients between 8 days after stroke onset randomly assigned to receive aspirin"	.

local:s6.1	a	rdf:Statement	;
	rdfs:label	"a subanalysis of the patients between 8 days after stroke onset receive clopidogrel alone"	.

local:s6	a	rdf:Statement	;
	rdfs:label	"in a subanalysis of the patients between 8 days after stroke onset randomly assigned to receive clopidogrel alone"	.

local:s5.3	a	rdf:Statement	;
	rdfs:label	"starting medication after stroke onset"	.

local:s5.2	a	rdf:Statement	;
	rdfs:label	"the effect of the dual medication differs according to timing of starting medication after stroke onset"	.

local:s5.1	a	rdf:Statement	;
	rdfs:label	"we determine whether the effect of the dual medication differs according to timing of starting medication after stroke onset"	.

local:s5	a	rdf:Statement	;
	rdfs:label	"aimed to determine whether the effect of the dual medication differs according to timing of starting medication after stroke onset"	.

local:s4.1	a	rdf:Statement	;
	rdfs:label	"monotherapy on risk of recurrent ischemic stroke"	.

local:s4	a	rdf:Statement	;
	rdfs:label	"the dual medication compared to monotherapy on risk of recurrent ischemic stroke"	.

local:s3	a	rdf:Statement	;
	rdfs:label	"longterm treatment with the combination of cilostazol with clopidogrel showed a lower risk of stroke recurrence compared to clopidogrel alone after highrisk noncardioembolic ischemic stroke in a randomized trial"	.

local:s2.1	a	rdf:Statement	;
	rdfs:label	"a lower risk of stroke recurrence compared to aspirin alone after highrisk noncardioembolic ischemic stroke in a randomized trial"	.

local:s2	a	rdf:Statement	;
	rdfs:label	"longterm treatment with the combination of cilostazol with clopidogrel showed a lower risk of stroke recurrence compared to aspirin alone after highrisk noncardioembolic ischemic stroke in a randomized trial"	.

local:s1	a	rdf:Statement	;
	rdfs:label	"longterm treatment with the combination of cilostazol with aspirin showed a lower risk of stroke recurrence compared to clopidogrel alone after highrisk noncardioembolic ischemic stroke in a randomized trial"	.

local:s0.1	a	rdf:Statement	;
	rdfs:label	"a lower risk of stroke recurrence compared to aspirin alone after highrisk noncardioembolic ischemic stroke in a randomized trial"	.

local:s0	a	rdf:Statement	;
	rdfs:label	"longterm treatment with the combination of cilostazol with aspirin showed a lower risk of stroke recurrence compared to aspirin alone after highrisk noncardioembolic ischemic stroke in a randomized trial"	.


#### Classes ####

local:hemorrhage	a	rdf:Class	;
	rdfs:label	"hemorrhage"	.

local:increase	a	rdf:Class	;
	rdfs:label	"increase"	.

local:longterm_dual_antiplatelet_therapy	a	rdf:Class	;
	rdfs:label	"longterm dual antiplatelet therapy"	.

local:antiplatelet_therapy	a	rdf:Class	;
	rdfs:label	"antiplatelet therapy"	.

local:therapy	a	rdf:Class	;
	rdfs:label	"therapy"	.

local:longterm_dual_antiplatelet	a	rdf:Class	;
	rdfs:label	"longterm dual antiplatelet"	.

local:antiplatelet	a	rdf:Class	;
	rdfs:label	"antiplatelet"	.

local:dual_antiplatelet	a	rdf:Class	;
	rdfs:label	"dual antiplatelet"	.

local:dual	a	rdf:Class	;
	rdfs:label	"dual"	.

local:longterm_dual	a	rdf:Class	;
	rdfs:label	"longterm dual"	.

local:dual_antiplatelet_therapy	a	rdf:Class	;
	rdfs:label	"dual antiplatelet therapy"	.

local:longterm	a	rdf:Class	;
	rdfs:label	"longterm"	.

local:start	a	rdf:Class	;
	rdfs:label	"start"	.

local:8_to_14_day_after_onset_be_more_effective_for_secondary_stroke_prevention_than_monotherapy_without_increase_hemorrhage_risk	a	rdf:Class	;
	rdfs:label	"8 to 14 day after onset be more effective for secondary stroke prevention than monotherapy without increase hemorrhage risk"	.

local:onset	a	rdf:Class	;
	rdfs:label	"onset"	.

local:secondary_stroke_prevention	a	rdf:Class	;
	rdfs:label	"secondary stroke prevention"	.

local:monotherapy	a	rdf:Class	;
	rdfs:label	"monotherapy"	.

local:increase_hemorrhage_risk	a	rdf:Class	;
	rdfs:label	"increase hemorrhage risk"	.

local:day	a	rdf:Class	;
	rdfs:label	"day"	.

local:hemorrhage_risk	a	rdf:Class	;
	rdfs:label	"hemorrhage risk"	.

local:increase_hemorrhage	a	rdf:Class	;
	rdfs:label	"increase hemorrhage"	.

local:secondary_stroke	a	rdf:Class	;
	rdfs:label	"secondary stroke"	.

local:stroke	a	rdf:Class	;
	rdfs:label	"stroke"	.

local:stroke_prevention	a	rdf:Class	;
	rdfs:label	"stroke prevention"	.

local:prevention	a	rdf:Class	;
	rdfs:label	"prevention"	.

local:secondary	a	rdf:Class	;
	rdfs:label	"secondary"	.

local:risk	a	rdf:Class	;
	rdfs:label	"risk"	.

local:more_effective	a	rdf:Class	;
	rdfs:label	"more effective"	.

local:effective	a	rdf:Class	;
	rdfs:label	"effective"	.

local:14_day	a	rdf:Class	;
	rdfs:label	"14 day"	.

local:8_14	a	rdf:Class	;
	rdfs:label	"8 14"	.

local:14	a	rdf:Class	;
	rdfs:label	"14"	.

local:14_day_after_onset	a	rdf:Class	;
	rdfs:label	"14 day after onset"	.

local:more_effective_for_secondary_stroke_prevention	a	rdf:Class	;
	rdfs:label	"more effective for secondary stroke prevention"	.

local:more_effective_for_secondary_stroke_prevention_than_monotherapy	a	rdf:Class	;
	rdfs:label	"more effective for secondary stroke prevention than monotherapy"	.

local:monotherapy_without_increase_hemorrhage_risk	a	rdf:Class	;
	rdfs:label	"monotherapy without increase hemorrhage risk"	.

local:15_to_180_day_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"15 to 180 day after stroke onset"	.

local:stroke_onset	a	rdf:Class	;
	rdfs:label	"stroke onset"	.

local:180_day	a	rdf:Class	;
	rdfs:label	"180 day"	.

local:15_180	a	rdf:Class	;
	rdfs:label	"15 180"	.

local:180	a	rdf:Class	;
	rdfs:label	"180"	.

local:compare	a	rdf:Class	;
	rdfs:label	"compare"	.

local:longterm_dual_antiplatelet_therapy_use_cilostazol	a	rdf:Class	;
	rdfs:label	"longterm dual antiplatelet therapy use cilostazol"	.

local:use_cilostazol	a	rdf:Class	;
	rdfs:label	"use cilostazol"	.

local:cilostazol	a	rdf:Class	;
	rdfs:label	"cilostazol"	.

local:longterm_dual_antiplatelet_therapy_use	a	rdf:Class	;
	rdfs:label	"longterm dual antiplatelet therapy use"	.

local:use	a	rdf:Class	;
	rdfs:label	"use"	.

local:antiplatelet_therapy_use	a	rdf:Class	;
	rdfs:label	"antiplatelet therapy use"	.

local:therapy_use	a	rdf:Class	;
	rdfs:label	"therapy use"	.

local:antiplatelet_therapy_use_cilostazol	a	rdf:Class	;
	rdfs:label	"antiplatelet therapy use cilostazol"	.

local:dual_antiplatelet_therapy_use_cilostazol	a	rdf:Class	;
	rdfs:label	"dual antiplatelet therapy use cilostazol"	.

local:dual_antiplatelet_therapy_use	a	rdf:Class	;
	rdfs:label	"dual antiplatelet therapy use"	.

local:therapy_use_cilostazol	a	rdf:Class	;
	rdfs:label	"therapy use cilostazol"	.

local:15_to_180_day	a	rdf:Class	;
	rdfs:label	"15 to 180 day"	.

local:stroke_onset_compare_to_therapy	a	rdf:Class	;
	rdfs:label	"stroke onset compare to therapy"	.

local:compare_to_therapy	a	rdf:Class	;
	rdfs:label	"compare to therapy"	.

local:severe_bleed	a	rdf:Class	;
	rdfs:label	"severe bleed"	.

local:bleed	a	rdf:Class	;
	rdfs:label	"bleed"	.

local:severe	a	rdf:Class	;
	rdfs:label	"severe"	.

local:occur	a	rdf:Class	;
	rdfs:label	"occur"	.

local:patient_on_dual_therapy	a	rdf:Class	;
	rdfs:label	"patient on dual therapy"	.

local:patient	a	rdf:Class	;
	rdfs:label	"patient"	.

local:dual_therapy	a	rdf:Class	;
	rdfs:label	"dual therapy"	.

local:trichotomized_group	a	rdf:Class	;
	rdfs:label	"trichotomized group"	.

local:group	a	rdf:Class	;
	rdfs:label	"group"	.

local:similarly	a	rdf:Class	;
	rdfs:label	"similarly"	.

local:lifethreatening_bleed	a	rdf:Class	;
	rdfs:label	"lifethreatening bleed"	.

local:lifethreatening	a	rdf:Class	;
	rdfs:label	"lifethreatening"	.

local:1879_patient_498	a	rdf:Class	;
	rdfs:label	"1879 patient 498"	.

local:498_patient	a	rdf:Class	;
	rdfs:label	"498 patient"	.

local:1879_498_patient	a	rdf:Class	;
	rdfs:label	"1879 498 patient"	.

local:belong	a	rdf:Class	;
	rdfs:label	"belong"	.

local:8_to_14_day_group_to_914_to_the_29_to_180_day_group	a	rdf:Class	;
	rdfs:label	"8 to 14 day group to 914 to the 29 to 180 day group"	.

local:day_group	a	rdf:Class	;
	rdfs:label	"day group"	.

local:180_day_group	a	rdf:Class	;
	rdfs:label	"180 day group"	.

local:29_180	a	rdf:Class	;
	rdfs:label	"29 180"	.

local:14_day_group	a	rdf:Class	;
	rdfs:label	"14 day group"	.

local:14_day_group_to_914	a	rdf:Class	;
	rdfs:label	"14 day group to 914"	.

local:914	a	rdf:Class	;
	rdfs:label	"914"	.

local:14_day_group_to_914_to_180_day_group	a	rdf:Class	;
	rdfs:label	"14 day group to 914 to 180 day group"	.

local:467	a	rdf:Class	;
	rdfs:label	"467"	.

local:15_to_28_day_group	a	rdf:Class	;
	rdfs:label	"15 to 28 day group"	.

local:28_day_group	a	rdf:Class	;
	rdfs:label	"28 day group"	.

local:15_28	a	rdf:Class	;
	rdfs:label	"15 28"	.

local:28	a	rdf:Class	;
	rdfs:label	"28"	.

local:467_to_914_to_the_29_to_180_day_group	a	rdf:Class	;
	rdfs:label	"467 to 914 to the 29 to 180 day group"	.

local:467_914	a	rdf:Class	;
	rdfs:label	"467 914"	.

local:467_914_to_180_day_group	a	rdf:Class	;
	rdfs:label	"467 914 to 180 day group"	.

local:8_to_14_day_group_to_the_15_to_28_day_group	a	rdf:Class	;
	rdfs:label	"8 to 14 day group to the 15 to 28 day group"	.

local:14_day_group_to_28_day_group	a	rdf:Class	;
	rdfs:label	"14 day group to 28 day group"	.

local:include	a	rdf:Class	;
	rdfs:label	"include"	.

local:safety_outcome_severe_bleed	a	rdf:Class	;
	rdfs:label	"safety outcome severe bleed"	.

local:safety_outcome	a	rdf:Class	;
	rdfs:label	"safety outcome"	.

local:outcome	a	rdf:Class	;
	rdfs:label	"outcome"	.

local:safety	a	rdf:Class	;
	rdfs:label	"safety"	.

local:safety_outcome_lifethreatening_bleed	a	rdf:Class	;
	rdfs:label	"safety outcome lifethreatening bleed"	.

local:safety_outcome_lifethreatening	a	rdf:Class	;
	rdfs:label	"safety outcome lifethreatening"	.

local:trial_treatment	a	rdf:Class	;
	rdfs:label	"trial treatment"	.

local:trial	a	rdf:Class	;
	rdfs:label	"trial"	.

local:treatment	a	rdf:Class	;
	rdfs:label	"treatment"	.

local:patient_between_8_day_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"patient between 8 day after stroke onset"	.

local:8_day	a	rdf:Class	;
	rdfs:label	"8 day"	.

local:patient_between_8_day	a	rdf:Class	;
	rdfs:label	"patient between 8 day"	.

local:divide	a	rdf:Class	;
	rdfs:label	"divide"	.

local:3_group	a	rdf:Class	;
	rdfs:label	"3 group"	.

local:accord_to_the_time_of_start_trial_treatment	a	rdf:Class	;
	rdfs:label	"accord to the time of start trial treatment"	.

local:start_trial_treatment	a	rdf:Class	;
	rdfs:label	"start trial treatment"	.

local:time	a	rdf:Class	;
	rdfs:label	"time"	.

local:accord	a	rdf:Class	;
	rdfs:label	"accord"	.

local:start_trial	a	rdf:Class	;
	rdfs:label	"start trial"	.

local:accord_to_time	a	rdf:Class	;
	rdfs:label	"accord to time"	.

local:time_of_start_trial_treatment	a	rdf:Class	;
	rdfs:label	"time of start trial treatment"	.

local:patient_between_180_day_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"patient between 180 day after stroke onset"	.

local:patient_between_180_day	a	rdf:Class	;
	rdfs:label	"patient between 180 day"	.

local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"subanalysis of the patient between 180 day after stroke onset"	.

local:subanalysis	a	rdf:Class	;
	rdfs:label	"subanalysis"	.

local:subanalysis_of_patient	a	rdf:Class	;
	rdfs:label	"subanalysis of patient"	.

local:subanalysis_of_patient_between_180_day	a	rdf:Class	;
	rdfs:label	"subanalysis of patient between 180 day"	.

local:subanalysis_of_patient_between_180_day_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"subanalysis of patient between 180 day after stroke onset"	.

local:receive	a	rdf:Class	;
	rdfs:label	"receive"	.

local:clopidogrel_alone	a	rdf:Class	;
	rdfs:label	"clopidogrel alone"	.

local:alone_clopidogrel	a	rdf:Class	;
	rdfs:label	"alone clopidogrel"	.

local:clopidogrel	a	rdf:Class	;
	rdfs:label	"clopidogrel"	.

local:assign	a	rdf:Class	;
	rdfs:label	"assign"	.

local:receive_clopidogrel_alone	a	rdf:Class	;
	rdfs:label	"receive clopidogrel alone"	.

local:receive_clopidogrel	a	rdf:Class	;
	rdfs:label	"receive clopidogrel"	.

local:alone_receive	a	rdf:Class	;
	rdfs:label	"alone receive"	.

local:randomly	a	rdf:Class	;
	rdfs:label	"randomly"	.

local:aspirin	a	rdf:Class	;
	rdfs:label	"aspirin"	.

local:receive_aspirin	a	rdf:Class	;
	rdfs:label	"receive aspirin"	.

local:randomize	a	rdf:Class	;
	rdfs:label	"randomize"	.

local:control	a	rdf:Class	;
	rdfs:label	"control"	.

local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"subanalysis of the patient between 8 day after stroke onset"	.

local:subanalysis_of_patient_between_8_day	a	rdf:Class	;
	rdfs:label	"subanalysis of patient between 8 day"	.

local:subanalysis_of_patient_between_8_day_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"subanalysis of patient between 8 day after stroke onset"	.

local:medication	a	rdf:Class	;
	rdfs:label	"medication"	.

local:effect_of_the_dual_medication	a	rdf:Class	;
	rdfs:label	"effect of the dual medication"	.

local:effect	a	rdf:Class	;
	rdfs:label	"effect"	.

local:dual_medication	a	rdf:Class	;
	rdfs:label	"dual medication"	.

local:effect_of_dual_medication	a	rdf:Class	;
	rdfs:label	"effect of dual medication"	.

local:differ	a	rdf:Class	;
	rdfs:label	"differ"	.

local:accord_to_time_of_start_medication_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"accord to time of start medication after stroke onset"	.

local:start_medication	a	rdf:Class	;
	rdfs:label	"start medication"	.

local:time_of_start_medication	a	rdf:Class	;
	rdfs:label	"time of start medication"	.

local:accord_to_time_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"accord to time after stroke onset"	.

local:we	a	rdf:Class	;
	rdfs:label	"we"	.

local:determine	a	rdf:Class	;
	rdfs:label	"determine"	.

local:whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"whether the effect of the dual medication differ accord to time of start medication after stroke onset"	.

local:dual_medication_differ_accord	a	rdf:Class	;
	rdfs:label	"dual medication differ accord"	.

local:dual_medication_differ	a	rdf:Class	;
	rdfs:label	"dual medication differ"	.

local:medication_differ	a	rdf:Class	;
	rdfs:label	"medication differ"	.

local:medication_differ_accord	a	rdf:Class	;
	rdfs:label	"medication differ accord"	.

local:differ_accord	a	rdf:Class	;
	rdfs:label	"differ accord"	.

local:dual_start_medication	a	rdf:Class	;
	rdfs:label	"dual start medication"	.

local:effect_of_dual_start_medication	a	rdf:Class	;
	rdfs:label	"effect of dual start medication"	.

local:differ_to_time	a	rdf:Class	;
	rdfs:label	"differ to time"	.

local:time_of_start_medication_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"time of start medication after stroke onset"	.

local:aim	a	rdf:Class	;
	rdfs:label	"aim"	.

local:determine_whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	a	rdf:Class	;
	rdfs:label	"determine whether the effect of the dual medication differ accord to time of start medication after stroke onset"	.

local:risk_of_recurrent_ischemic_stroke	a	rdf:Class	;
	rdfs:label	"risk of recurrent ischemic stroke"	.

local:recurrent_ischemic_stroke	a	rdf:Class	;
	rdfs:label	"recurrent ischemic stroke"	.

local:recurrent_ischemic	a	rdf:Class	;
	rdfs:label	"recurrent ischemic"	.

local:ischemic	a	rdf:Class	;
	rdfs:label	"ischemic"	.

local:ischemic_stroke	a	rdf:Class	;
	rdfs:label	"ischemic stroke"	.

local:recurrent	a	rdf:Class	;
	rdfs:label	"recurrent"	.

local:longterm_treatment_with_the_combination_of_cilostazol_with_clopidogrel	a	rdf:Class	;
	rdfs:label	"longterm treatment with the combination of cilostazol with clopidogrel"	.

local:combination	a	rdf:Class	;
	rdfs:label	"combination"	.

local:longterm_treatment	a	rdf:Class	;
	rdfs:label	"longterm treatment"	.

local:longterm_treatment_with_combination	a	rdf:Class	;
	rdfs:label	"longterm treatment with combination"	.

local:combination_of_cilostazol	a	rdf:Class	;
	rdfs:label	"combination of cilostazol"	.

local:longterm_treatment_with_combination_with_clopidogrel	a	rdf:Class	;
	rdfs:label	"longterm treatment with combination with clopidogrel"	.

local:show	a	rdf:Class	;
	rdfs:label	"show"	.

local:lower_risk_of_stroke_recurrence_compare_to_clopidogrel_alone	a	rdf:Class	;
	rdfs:label	"lower risk of stroke recurrence compare to clopidogrel alone"	.

local:stroke_recurrence_compare	a	rdf:Class	;
	rdfs:label	"stroke recurrence compare"	.

local:lower_risk	a	rdf:Class	;
	rdfs:label	"lower risk"	.

local:lower	a	rdf:Class	;
	rdfs:label	"lower"	.

local:stroke_recurrence	a	rdf:Class	;
	rdfs:label	"stroke recurrence"	.

local:recurrence_compare	a	rdf:Class	;
	rdfs:label	"recurrence compare"	.

local:recurrence	a	rdf:Class	;
	rdfs:label	"recurrence"	.

local:alone_compare	a	rdf:Class	;
	rdfs:label	"alone compare"	.

local:lower_risk_of_stroke_recurrence	a	rdf:Class	;
	rdfs:label	"lower risk of stroke recurrence"	.

local:alone_compare_to_clopidogrel	a	rdf:Class	;
	rdfs:label	"alone compare to clopidogrel"	.

local:highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	a	rdf:Class	;
	rdfs:label	"highrisk noncardioembolic ischemic stroke in a randomize trial"	.

local:randomize_trial	a	rdf:Class	;
	rdfs:label	"randomize trial"	.

local:highrisk	a	rdf:Class	;
	rdfs:label	"highrisk"	.

local:noncardioembolic_ischemic_stroke	a	rdf:Class	;
	rdfs:label	"noncardioembolic ischemic stroke"	.

local:noncardioembolic_ischemic	a	rdf:Class	;
	rdfs:label	"noncardioembolic ischemic"	.

local:noncardioembolic	a	rdf:Class	;
	rdfs:label	"noncardioembolic"	.

local:highrisk_noncardioembolic_ischemic_stroke	a	rdf:Class	;
	rdfs:label	"highrisk noncardioembolic ischemic stroke"	.

local:highrisk_noncardioembolic_ischemic_stroke_in_randomize_trial	a	rdf:Class	;
	rdfs:label	"highrisk noncardioembolic ischemic stroke in randomize trial"	.

local:aspirin_alone_after_highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	a	rdf:Class	;
	rdfs:label	"aspirin alone after highrisk noncardioembolic ischemic stroke in a randomize trial"	.

local:highrisk_noncardioembolic	a	rdf:Class	;
	rdfs:label	"highrisk noncardioembolic"	.

local:highrisk_noncardioembolic_ischemic	a	rdf:Class	;
	rdfs:label	"highrisk noncardioembolic ischemic"	.

local:alone_aspirin	a	rdf:Class	;
	rdfs:label	"alone aspirin"	.

local:alone_aspirin_after_highrisk_noncardioembolic_ischemic_stroke	a	rdf:Class	;
	rdfs:label	"alone aspirin after highrisk noncardioembolic ischemic stroke"	.

local:alone_aspirin_after_highrisk_noncardioembolic_ischemic_stroke_in_randomize_trial	a	rdf:Class	;
	rdfs:label	"alone aspirin after highrisk noncardioembolic ischemic stroke in randomize trial"	.

local:lower_risk_of_stroke_recurrence_compare_to_aspirin_alone	a	rdf:Class	;
	rdfs:label	"lower risk of stroke recurrence compare to aspirin alone"	.

local:alone_compare_to_aspirin	a	rdf:Class	;
	rdfs:label	"alone compare to aspirin"	.

local:longterm_treatment_with_the_combination_of_cilostazol_with_aspirin	a	rdf:Class	;
	rdfs:label	"longterm treatment with the combination of cilostazol with aspirin"	.

local:longterm_treatment_with_combination_with_aspirin	a	rdf:Class	;
	rdfs:label	"longterm treatment with combination with aspirin"	.

#### Mapped Relations ####

ncit:C1051	rdfs:label	"Cilostazol"	.
local:stroke	owl:sameAs	ncit:C3390	.
ncit:C95802	rdfs:label	"Ischemic Cerebrovascular Accident"	.
local:effective	owl:sameAs	ncit:C49287	.
local:determine	owl:sameAs	ncit:C136827	.
ncit:C61299	rdfs:label	"Control"	.
local:combination	owl:sameAs	ncit:C61517	.
ncit:C86568	rdfs:label	"Lower"	.
ncit:C17266	rdfs:label	"Congo the Democratic Republic of the"	.
ncit:C459	rdfs:label	"Medication"	.
local:occur	owl:sameAs	ncit:C54069	.
ncit:C71104	rdfs:label	"Clinical Trial"	.
ncit:C49287	rdfs:label	"Effective"	.
local:time	owl:sameAs	ncit:C25207	.
ncit:C123752	rdfs:label	"GENC Entity 6"	.
local:group	owl:sameAs	ncit:C43359	.
local:outcome	owl:sameAs	ncit:C20200	.
local:180	owl:sameAs	ncit:C17266	.
ncit:C60761	rdfs:label	"Aim"	.
local:prevention	owl:sameAs	ncit:C15843	.
local:day	owl:sameAs	ncit:C25301	.
ncit:C3390	rdfs:label	"Stroke"	.
local:safety	owl:sameAs	ncit:C60828	.
ncit:C176777	rdfs:label	"Collagen Tile Brachytherapy"	.
ncit:C25340	rdfs:label	"Use"	.
ncit:C25301	rdfs:label	"Day"	.
ncit:C54069	rdfs:label	"Occur"	.
ncit:C43359	rdfs:label	"Group"	.
local:aim	owl:sameAs	ncit:C60761	.
local:effect	owl:sameAs	ncit:C25492	.
ncit:C25426	rdfs:label	"Assignment"	.
ncit:C60828	rdfs:label	"Safety"	.
ncit:C3352	rdfs:label	"Recurrence"	.
local:914	owl:sameAs	ncit:C123752	.
local:therapy	owl:sameAs	ncit:C49236	.
local:recurrence	owl:sameAs	ncit:C3352	.
ncit:C49156	rdfs:label	"Comparison"	.
ncit:C25533	rdfs:label	"Increase"	.
ncit:C61517	rdfs:label	"Combination"	.
local:recurrent	owl:sameAs	ncit:C14173	.
ncit:C17102	rdfs:label	"Risk"	.
ncit:C15843	rdfs:label	"Preventive Intervention"	.
ncit:C62265	rdfs:label	"Double"	.
local:include	owl:sameAs	ncit:C74521	.
local:medication	owl:sameAs	ncit:C459	.
ncit:C25492	rdfs:label	"Effect"	.
ncit:C136827	rdfs:label	"Determine"	.
local:ischemic_stroke	owl:sameAs	ncit:C95802	.
local:treatment	owl:sameAs	ncit:C49656	.
local:secondary	owl:sameAs	ncit:C25667	.
ncit:C26791	rdfs:label	"Hemorrhage"	.
local:receive	owl:sameAs	ncit:C25639	.
local:cilostazol	owl:sameAs	ncit:C1051	.
ncit:C25207	rdfs:label	"Time"	.
local:increase	owl:sameAs	ncit:C25533	.
ncit:C25667	rdfs:label	"Secondary"	.
local:use	owl:sameAs	ncit:C25340	.
local:hemorrhage	owl:sameAs	ncit:C26791	.
ncit:C49236	rdfs:label	"Therapeutic Procedure"	.
ncit:C49656	rdfs:label	"Treatment Study"	.
local:dual	owl:sameAs	ncit:C62265	.
local:start	owl:sameAs	ncit:C176777	.
ncit:C20200	rdfs:label	"Outcome"	.
ncit:C64659	rdfs:label	"Divide"	.
ncit:C25639	rdfs:label	"Receive"	.
local:assign	owl:sameAs	ncit:C25426	.
ncit:C70667	rdfs:label	"Severe"	.
ncit:C16960	rdfs:label	"Patient"	.
ncit:C74521	rdfs:label	"Include"	.
local:patient	owl:sameAs	ncit:C16960	.
local:divide	owl:sameAs	ncit:C64659	.
local:severe	owl:sameAs	ncit:C70667	.
local:risk	owl:sameAs	ncit:C17102	.
local:compare	owl:sameAs	ncit:C49156	.
local:control	owl:sameAs	ncit:C61299	.
ncit:C14173	rdfs:label	"Recurrent"	.
local:lower	owl:sameAs	ncit:C86568	.
local:trial	owl:sameAs	ncit:C71104	.

#### Relations ####

local:start_medication	rdfs:member	local:start	.
local:antiplatelet_therapy	rdfs:subClassOf	local:therapy	.
local:patient_between_8_day_after_stroke_onset	rdfs:member	local:day	.
local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:lower_risk_of_stroke_recurrence_compare_to_clopidogrel_alone	rdfs:member	local:stroke_recurrence_compare	.
local:dual_antiplatelet_therapy_use_cilostazol	rdfs:subClassOf	local:cilostazol	.
local:highrisk_noncardioembolic	rdfs:member	local:highrisk	.
local:patient_between_8_day_after_stroke_onset	rdfs:member	local:patient	.
local:s13	local:AM-MNR	local:randomly	.
local:s6	local:AM-TMP	local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	.
local:s2	rdf:subject	local:longterm_treatment_with_the_combination_of_cilostazol_with_clopidogrel	.
local:receive_aspirin	rdfs:member	local:receive	.
local:effect_of_dual_start_medication	rdfs:member	local:effect	.
local:receive_clopidogrel	rdfs:subClassOf	local:clopidogrel	.
local:stroke_prevention	rdfs:subClassOf	local:prevention	.
local:s7.1	rdf:predicate	local:receive	.
local:patient_between_180_day_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:highrisk_noncardioembolic_ischemic_stroke	rdfs:member	local:highrisk_noncardioembolic_ischemic	.
local:s43.1	rdf:predicate	local:occur	.
local:highrisk_noncardioembolic	rdfs:subClassOf	local:noncardioembolic	.
local:highrisk_noncardioembolic_ischemic_stroke	rdfs:subClassOf	local:noncardioembolic_ischemic_stroke	.
local:longterm_dual_antiplatelet_therapy_use	rdfs:member	local:longterm_dual_antiplatelet_therapy	.
local:s42.1	local:AM-LOC	local:trichotomized_group	.
local:s5.1	rdf:predicate	local:determine	.
local:s16.1	rdf:subject	local:trial_treatment	.
local:s13.1	rdf:predicate	local:receive	.
local:more_effective_for_secondary_stroke_prevention_than_monotherapy	rdfs:member	local:more_effective_for_secondary_stroke_prevention	.
local:alone_compare_to_clopidogrel	rdfs:member	local:clopidogrel	.
local:start_trial	rdfs:subClassOf	local:trial	.
local:secondary_stroke_prevention	rdfs:member	local:secondary_stroke	.
local:s45.2	rdf:predicate	local:compare	.
local:s33	rdf:predicate	local:belong	.
local:longterm_treatment_with_combination	rdfs:member	local:longterm_treatment	.
local:lower_risk_of_stroke_recurrence	rdfs:member	local:stroke_recurrence	.
local:alone_clopidogrel	rdfs:subClassOf	local:clopidogrel	.
local:14_day	rdfs:subClassOf	local:day	.
local:s16	rdf:object	local:3_group	.
local:s41	rdf:predicate	local:occur	.
local:noncardioembolic_ischemic	rdfs:subClassOf	local:ischemic	.
local:recurrent_ischemic	rdfs:subClassOf	local:ischemic	.
local:8_to_14_day_after_onset_be_more_effective_for_secondary_stroke_prevention_than_monotherapy_without_increase_hemorrhage_risk	rdfs:member	local:onset	.
local:risk_of_recurrent_ischemic_stroke	rdfs:member	local:recurrent_ischemic_stroke	.
local:14_day_group_to_914_to_180_day_group	rdfs:member	local:14_day_group_to_914	.
local:s44	local:AM-LOC	local:patient_on_dual_therapy	.
local:467_914_to_180_day_group	rdfs:member	local:180_day_group	.
local:s33	rdf:subject	local:1879_patient_498	.
local:14_day_after_onset	rdfs:member	local:onset	.
local:s43.1	rdf:subject	local:lifethreatening_bleed	.
local:start_trial_treatment	rdfs:subClassOf	local:treatment	.
local:use_cilostazol	rdfs:member	local:use	.
local:dual_therapy	rdfs:subClassOf	local:therapy	.
local:8_to_14_day_after_onset_be_more_effective_for_secondary_stroke_prevention_than_monotherapy_without_increase_hemorrhage_risk	rdfs:member	local:secondary_stroke_prevention	.
local:accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:start_medication	.
local:more_effective_for_secondary_stroke_prevention	rdfs:member	local:secondary_stroke_prevention	.
local:therapy_use_cilostazol	rdfs:member	local:therapy_use	.
local:increase_hemorrhage_risk	rdfs:subClassOf	local:hemorrhage_risk	.
local:longterm_dual_antiplatelet_therapy_use_cilostazol	rdfs:subClassOf	local:dual_antiplatelet_therapy_use_cilostazol	.
local:s11	rdf:object	local:receive_aspirin	.
local:s5	rdf:object	local:determine_whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	.
local:subanalysis_of_patient_between_180_day_after_stroke_onset	rdfs:member	local:subanalysis_of_patient_between_180_day	.
local:dual_medication_differ_accord	rdfs:subClassOf	local:accord	.
local:time_of_start_medication_after_stroke_onset	rdfs:member	local:time_of_start_medication	.
local:s42.1	local:AM-MNR	local:similarly	.
local:s9	rdf:predicate	local:control	.
local:s5.2	rdf:subject	local:effect_of_the_dual_medication	.
local:s0	rdf:subject	local:longterm_treatment_with_the_combination_of_cilostazol_with_aspirin	.
local:s11.1	rdf:object	local:aspirin	.
local:compare_to_therapy	rdfs:member	local:therapy	.
local:s2.1	rdf:object	local:aspirin_alone_after_highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	.
local:s33	rdf:object	local:467_to_914_to_the_29_to_180_day_group	.
local:s5.1	rdf:object	local:whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	.
local:aspirin_alone_after_highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	rdfs:member	local:highrisk_noncardioembolic_ischemic_stroke	.
local:alone_compare	rdfs:subClassOf	local:compare	.
local:dual_antiplatelet_therapy	rdfs:subClassOf	local:therapy	.
local:dual_antiplatelet_therapy_use	rdfs:member	local:dual_antiplatelet_therapy	.
local:s34	rdf:subject	local:1879_patient_498	.
local:s9	rdf:subject	local:randomize	.
local:time_of_start_trial_treatment	rdfs:member	local:time	.
local:3_group	rdfs:subClassOf	local:group	.
local:s1	rdf:object	local:lower_risk_of_stroke_recurrence_compare_to_clopidogrel_alone	.
local:s0	rdf:predicate	local:show	.
local:s7.1	rdf:object	local:aspirin	.
local:compare_to_therapy	rdfs:member	local:compare	.
local:use_cilostazol	rdfs:subClassOf	local:cilostazol	.
local:safety_outcome_severe_bleed	rdfs:member	local:severe_bleed	.
local:start_trial	rdfs:member	local:start	.
local:longterm_treatment_with_the_combination_of_cilostazol_with_aspirin	rdfs:member	local:longterm_treatment	.
local:s34	rdf:object	local:467	.
local:patient_between_8_day	rdfs:member	local:8_day	.
local:alone_aspirin	rdfs:subClassOf	local:aspirin	.
local:s45	rdf:subject	local:longterm_dual_antiplatelet_therapy	.
local:longterm_treatment_with_the_combination_of_cilostazol_with_aspirin	rdfs:member	local:aspirin	.
local:8_to_14_day_after_onset_be_more_effective_for_secondary_stroke_prevention_than_monotherapy_without_increase_hemorrhage_risk	rdfs:member	local:monotherapy	.
local:14_day_group_to_28_day_group	rdfs:member	local:14_day_group	.
local:receive_clopidogrel	rdfs:member	local:receive	.
local:s5	rdf:predicate	local:aim	.
local:patient_between_180_day	rdfs:member	local:patient	.
local:highrisk_noncardioembolic_ischemic_stroke_in_randomize_trial	rdfs:member	local:randomize_trial	.
local:s13	rdf:predicate	local:assign	.
local:time_of_start_medication	rdfs:member	local:time	.
local:s15.1	rdf:predicate	local:start	.
local:s13	local:AM-TMP	local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	.
local:dual_medication_differ	rdfs:subClassOf	local:differ	.
local:highrisk_noncardioembolic_ischemic_stroke_in_randomize_trial	rdfs:member	local:highrisk_noncardioembolic_ischemic_stroke	.
local:safety_outcome_severe_bleed	rdfs:member	local:safety_outcome	.
local:dual_therapy	rdfs:member	local:dual	.
local:longterm_treatment_with_the_combination_of_cilostazol_with_clopidogrel	rdfs:member	local:cilostazol	.
local:trial_treatment	rdfs:member	local:trial	.
local:patient_between_8_day	rdfs:member	local:patient	.
local:s45.2	rdf:subject	local:15_to_180_day_after_stroke_onset	.
local:patient_on_dual_therapy	rdfs:member	local:dual_therapy	.
local:s3	rdf:subject	local:longterm_treatment_with_the_combination_of_cilostazol_with_clopidogrel	.
local:determine_whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:determine	.
local:s6.1	rdf:predicate	local:receive	.
local:s11.1	rdf:subject	local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	.
local:determine_whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:effect	.
local:s5.3	rdf:subject	local:medication	.
local:time_of_start_trial_treatment	rdfs:member	local:start_trial_treatment	.
local:s6.1	rdf:subject	local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	.
local:s42	rdf:predicate	local:lifethreatening	.
local:antiplatelet_therapy_use	rdfs:member	local:antiplatelet_therapy	.
local:patient_on_dual_therapy	rdfs:member	local:patient	.
local:s45	rdf:object	local:cilostazol	.
local:s13.1	rdf:object	local:clopidogrel_alone	.
local:noncardioembolic_ischemic_stroke	rdfs:member	local:noncardioembolic_ischemic	.
local:s45.1	local:AM-TMP	local:stroke_onset_compare_to_therapy	.
local:subanalysis_of_patient	rdfs:member	local:patient	.
local:s16.1	rdf:predicate	local:start	.
local:s6.1	rdf:object	local:clopidogrel_alone	.
local:dual_medication_differ_accord	rdfs:member	local:dual_medication_differ	.
local:s46	rdf:subject	local:longterm_dual_antiplatelet_therapy	.
local:start_trial_treatment	rdfs:member	local:start_trial	.
local:s4	rdf:object	local:s4.1	.
local:differ_accord	rdfs:subClassOf	local:accord	.
local:subanalysis_of_patient	rdfs:member	local:subanalysis	.
local:dual_antiplatelet_therapy_use	rdfs:subClassOf	local:use	.
local:subanalysis_of_patient_between_8_day	rdfs:member	local:subanalysis_of_patient	.
local:longterm_dual_antiplatelet_therapy_use	rdfs:subClassOf	local:use	.
local:s2	local:AM-TMP	local:highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	.
local:s43.1	local:AM-LOC	local:patient_on_dual_therapy	.
local:subanalysis_of_patient_between_8_day_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:s2	rdf:predicate	local:show	.
local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	rdfs:member	local:day	.
local:therapy_use_cilostazol	rdfs:subClassOf	local:use_cilostazol	.
local:randomize_trial	rdfs:member	local:randomize	.
local:longterm_treatment_with_combination_with_aspirin	rdfs:member	local:aspirin	.
local:safety_outcome_lifethreatening	rdfs:member	local:lifethreatening	.
local:longterm_dual_antiplatelet_therapy_use_cilostazol	rdfs:member	local:longterm_dual_antiplatelet_therapy_use	.
local:longterm_treatment_with_combination_with_aspirin	rdfs:member	local:longterm_treatment_with_combination	.
local:s43.1	local:AM-LOC	local:trichotomized_group	.
local:secondary_stroke_prevention	rdfs:subClassOf	local:prevention	.
local:s5.1	rdf:subject	local:we	.
local:antiplatelet_therapy_use_cilostazol	rdfs:member	local:antiplatelet_therapy_use	.
local:29_180	rdfs:subClassOf	local:180	.
local:dual_antiplatelet_therapy_use_cilostazol	rdfs:member	local:dual_antiplatelet_therapy_use	.
local:longterm_dual_antiplatelet	rdfs:member	local:longterm_dual	.
local:time_of_start_medication	rdfs:member	local:start_medication	.
local:lower_risk	rdfs:member	local:lower	.
local:recurrent_ischemic_stroke	rdfs:subClassOf	local:ischemic_stroke	.
local:highrisk_noncardioembolic_ischemic	rdfs:member	local:highrisk_noncardioembolic	.
local:s46.1	rdf:subject	local:hemorrhage	.
local:s7	local:AM-MNR	local:randomly	.
local:s6	rdf:object	local:receive_clopidogrel_alone	.
local:patient_between_180_day_after_stroke_onset	rdfs:member	local:day	.
local:s32	rdf:predicate	local:belong	.
local:s42.1	local:AM-LOC	local:monotherapy	.
local:recurrent_ischemic_stroke	rdfs:subClassOf	local:stroke	.
local:s5.2	rdf:predicate	local:differ	.
local:8_day	rdfs:subClassOf	local:day	.
local:s7	local:AM-TMP	local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	.
local:highrisk_noncardioembolic_ischemic_stroke	rdfs:subClassOf	local:stroke	.
local:14_day_group_to_914	rdfs:member	local:14_day_group	.
local:whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:dual_medication_differ_accord	.
local:recurrent_ischemic_stroke	rdfs:member	local:recurrent_ischemic	.
local:s16	rdf:predicate	local:divide	.
local:longterm_dual_antiplatelet	rdfs:subClassOf	local:antiplatelet	.
local:s46	rdf:predicate	local:start	.
local:alone_aspirin_after_highrisk_noncardioembolic_ischemic_stroke_in_randomize_trial	rdfs:member	local:alone_aspirin_after_highrisk_noncardioembolic_ischemic_stroke	.
local:receive_aspirin	rdfs:subClassOf	local:aspirin	.
local:s30	rdf:predicate	local:include	.
local:s15	rdf:predicate	local:divide	.
local:s42	rdf:subject	local:bleed	.
local:8_to_14_day_after_onset_be_more_effective_for_secondary_stroke_prevention_than_monotherapy_without_increase_hemorrhage_risk	rdfs:member	local:day	.
local:s0.1	rdf:predicate	local:compare	.
local:s34	local:AM-TMP	local:15_to_28_day_group	.
local:498_patient	rdfs:subClassOf	local:patient	.
local:s41	local:AM-LOC	local:monotherapy	.
local:s35	rdf:subject	local:1879_patient_498	.
local:s13.1	rdf:subject	local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	.
local:s4	rdf:predicate	local:compare	.
local:antiplatelet_therapy	rdfs:member	local:antiplatelet	.
local:recurrence_compare	rdfs:member	local:recurrence	.
local:15_to_180_day_after_stroke_onset	rdfs:member	local:day	.
local:s41	local:AM-MNR	local:similarly	.
local:s42.1	rdf:predicate	local:occur	.
local:s4.1	rdf:predicate	local:monotherapy	.
local:8_to_14_day_after_onset_be_more_effective_for_secondary_stroke_prevention_than_monotherapy_without_increase_hemorrhage_risk	rdfs:member	local:increase_hemorrhage_risk	.
local:whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:time	.
local:15_28	rdfs:subClassOf	local:28	.
local:14_day_group_to_914	rdfs:member	local:914	.
local:s7	rdf:object	local:receive_aspirin	.
local:longterm_treatment_with_combination_with_clopidogrel	rdfs:member	local:longterm_treatment_with_combination	.
local:14_day_group_to_28_day_group	rdfs:member	local:28_day_group	.
local:increase_hemorrhage	rdfs:subClassOf	local:hemorrhage	.
local:467_914_to_180_day_group	rdfs:member	local:467_914	.
local:s31	rdf:predicate	local:include	.
local:s2.1	rdf:subject	local:lower_risk_of_stroke_recurrence	.
local:s15.1	rdf:subject	local:trial_treatment	.
local:increase_hemorrhage	rdfs:member	local:increase	.
local:s2	rdf:object	local:lower_risk_of_stroke_recurrence_compare_to_aspirin_alone	.
local:s7.1	rdf:subject	local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	.
local:s1	rdf:subject	local:longterm_treatment_with_the_combination_of_cilostazol_with_aspirin	.
local:longterm_treatment_with_combination_with_clopidogrel	rdfs:member	local:clopidogrel	.
local:alone_aspirin_after_highrisk_noncardioembolic_ischemic_stroke	rdfs:member	local:highrisk_noncardioembolic_ischemic_stroke	.
local:s32	rdf:subject	local:1879_patient_498	.
local:alone_compare_to_clopidogrel	rdfs:member	local:alone_compare	.
local:whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:dual_medication_differ	rdfs:member	local:dual_medication	.
local:s46	local:AM-TMP	local:8_to_14_day_after_onset_be_more_effective_for_secondary_stroke_prevention_than_monotherapy_without_increase_hemorrhage_risk	.
local:aspirin_alone_after_highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	rdfs:member	local:randomize_trial	.
local:s0.1	rdf:subject	local:lower_risk_of_stroke_recurrence	.
local:s0	rdf:object	local:lower_risk_of_stroke_recurrence_compare_to_aspirin_alone	.
local:monotherapy_without_increase_hemorrhage_risk	rdfs:member	local:increase_hemorrhage_risk	.
local:determine_whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:time	.
local:subanalysis_of_patient_between_8_day_after_stroke_onset	rdfs:member	local:subanalysis_of_patient_between_8_day	.
local:aspirin_alone_after_highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	rdfs:member	local:aspirin	.
local:secondary_stroke	rdfs:subClassOf	local:stroke	.
local:s41	rdf:subject	local:severe_bleed	.
local:longterm_treatment_with_the_combination_of_cilostazol_with_aspirin	rdfs:member	local:combination	.
local:start_medication	rdfs:subClassOf	local:medication	.
local:15_to_180_day_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:s45.1	rdf:subject	local:longterm_dual_antiplatelet_therapy_use_cilostazol	.
local:longterm_treatment	rdfs:member	local:longterm	.
local:antiplatelet_therapy_use_cilostazol	rdfs:subClassOf	local:cilostazol	.
local:lower_risk_of_stroke_recurrence_compare_to_aspirin_alone	rdfs:member	local:lower_risk	.
local:stroke_recurrence_compare	rdfs:subClassOf	local:compare	.
local:effect_of_dual_medication	rdfs:member	local:dual_medication	.
local:medication_differ_accord	rdfs:member	local:medication_differ	.
local:longterm_treatment_with_the_combination_of_cilostazol_with_clopidogrel	rdfs:member	local:clopidogrel	.
local:dual_antiplatelet_therapy	rdfs:member	local:dual_antiplatelet	.
local:accord_to_the_time_of_start_trial_treatment	rdfs:member	local:time	.
local:s31	rdf:object	local:safety_outcome_severe_bleed	.
local:alone_compare_to_aspirin	rdfs:member	local:aspirin	.
local:safety_outcome_lifethreatening_bleed	rdfs:member	local:bleed	.
local:severe_bleed	rdfs:member	local:severe	.
local:s11.1	rdf:predicate	local:receive	.
local:longterm_dual	rdfs:subClassOf	local:dual	.
local:28_day_group	rdfs:subClassOf	local:day_group	.
local:longterm_treatment_with_combination	rdfs:member	local:combination	.
local:s1	rdf:predicate	local:show	.
local:s15	rdf:object	local:3_group	.
local:s3	local:AM-TMP	local:highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	.
local:s5.3	local:AM-TMP	local:stroke_onset	.
local:s7	rdf:predicate	local:assign	.
local:lower_risk	rdfs:subClassOf	local:risk	.
local:longterm_dual_antiplatelet_therapy	rdfs:member	local:longterm_dual_antiplatelet	.
local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:recurrent_ischemic	rdfs:member	local:recurrent	.
local:s42.1	rdf:subject	local:lifethreatening_bleed	.
local:accord_to_time	rdfs:member	local:time	.
local:time_of_start_medication_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:hemorrhage_risk	rdfs:subClassOf	local:risk	.
local:lower_risk_of_stroke_recurrence_compare_to_aspirin_alone	rdfs:member	local:stroke_recurrence_compare	.
local:s35	rdf:predicate	local:belong	.
local:15_180	rdfs:subClassOf	local:180	.
local:s43	rdf:predicate	local:lifethreatening	.
local:longterm_treatment	rdfs:subClassOf	local:treatment	.
local:subanalysis_of_patient_between_180_day	rdfs:member	local:180_day	.
local:increase_hemorrhage_risk	rdfs:subClassOf	local:risk	.
local:s5.2	local:AM-ADV	local:accord_to_time_of_start_medication_after_stroke_onset	.
local:differ_to_time	rdfs:member	local:time	.
local:14_day_group_to_914_to_180_day_group	rdfs:member	local:180_day_group	.
local:longterm_treatment_with_the_combination_of_cilostazol_with_clopidogrel	rdfs:member	local:combination	.
local:increase_hemorrhage_risk	rdfs:member	local:increase_hemorrhage	.
local:therapy_use_cilostazol	rdfs:subClassOf	local:cilostazol	.
local:effect_of_the_dual_medication	rdfs:member	local:effect	.
local:patient_between_8_day_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:accord_to_time_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:alone_receive	rdfs:subClassOf	local:receive	.
local:whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:start_medication	.
local:s46.1	rdf:predicate	local:increase	.
local:s9	rdf:object	local:trial	.
local:stroke_recurrence	rdfs:member	local:stroke	.
local:14_day_group	rdfs:subClassOf	local:day_group	.
local:dual_start_medication	rdfs:subClassOf	local:start_medication	.
local:s44	rdf:subject	local:severe_bleed	.
local:medication_differ	rdfs:subClassOf	local:differ	.
local:effect_of_the_dual_medication	rdfs:member	local:dual_medication	.
local:dual_antiplatelet_therapy_use_cilostazol	rdfs:subClassOf	local:antiplatelet_therapy_use_cilostazol	.
local:monotherapy_without_increase_hemorrhage_risk	rdfs:member	local:monotherapy	.
local:accord_to_time_after_stroke_onset	rdfs:member	local:accord_to_time	.
local:s35	rdf:object	local:8_to_14_day_group_to_914_to_the_29_to_180_day_group	.
local:more_effective	rdfs:subClassOf	local:effective	.
local:secondary_stroke	rdfs:member	local:secondary	.
local:ischemic_stroke	rdfs:subClassOf	local:stroke	.
local:trichotomized_group	rdfs:subClassOf	local:group	.
local:s45.1	rdf:predicate	local:start	.
local:180_day	rdfs:subClassOf	local:day	.
local:accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:s0.1	rdf:object	local:aspirin_alone_after_highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	.
local:s3	rdf:predicate	local:show	.
local:medication_differ_accord	rdfs:subClassOf	local:accord	.
local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	rdfs:member	local:patient	.
local:trial_treatment	rdfs:subClassOf	local:treatment	.
local:s32	rdf:object	local:8_to_14_day_group_to_the_15_to_28_day_group	.
local:patient_between_180_day	rdfs:member	local:180_day	.
local:s6	rdf:predicate	local:assign	.
local:longterm_treatment_with_the_combination_of_cilostazol_with_aspirin	rdfs:member	local:cilostazol	.
local:s3	rdf:object	local:lower_risk_of_stroke_recurrence_compare_to_clopidogrel_alone	.
local:recurrence_compare	rdfs:subClassOf	local:compare	.
local:combination_of_cilostazol	rdfs:member	local:combination	.
local:subanalysis_of_patient_between_8_day	rdfs:member	local:8_day	.
local:determine_whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:start_medication	.
local:s15	local:AM-ADV	local:accord_to_the_time_of_start_trial_treatment	.
local:longterm_dual_antiplatelet_therapy	rdfs:subClassOf	local:dual_antiplatelet_therapy	.
local:accord_to_the_time_of_start_trial_treatment	rdfs:member	local:start_trial_treatment	.
local:s0	local:AM-TMP	local:highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	.
local:s11	local:AM-TMP	local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	.
local:stroke_onset	rdfs:subClassOf	local:onset	.
local:s44	local:AM-LOC	local:trichotomized_group	.
local:stroke_onset	rdfs:member	local:stroke	.
local:start_trial_treatment	rdfs:subClassOf	local:trial_treatment	.
local:day_group	rdfs:subClassOf	local:group	.
local:s43	rdf:subject	local:bleed	.
local:risk_of_recurrent_ischemic_stroke	rdfs:member	local:risk	.
local:s16	local:AM-ADV	local:accord_to_the_time_of_start_trial_treatment	.
local:day_group	rdfs:member	local:day	.
local:accord_to_time	rdfs:member	local:accord	.
local:combination_of_cilostazol	rdfs:member	local:cilostazol	.
local:s30	rdf:object	local:safety_outcome_lifethreatening_bleed	.
local:s1	local:AM-TMP	local:highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	.
local:s41	local:AM-LOC	local:trichotomized_group	.
local:highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	rdfs:member	local:noncardioembolic_ischemic_stroke	.
local:effect_of_dual_medication	rdfs:member	local:effect	.
local:longterm_dual	rdfs:member	local:longterm	.
local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	rdfs:member	local:subanalysis	.
local:therapy_use	rdfs:member	local:therapy	.
local:s13	rdf:object	local:receive_clopidogrel_alone	.
local:antiplatelet_therapy_use	rdfs:subClassOf	local:use	.
local:patient_between_180_day_after_stroke_onset	rdfs:member	local:patient_between_180_day	.
local:safety_outcome_lifethreatening	rdfs:member	local:safety_outcome	.
local:effect_of_dual_start_medication	rdfs:member	local:dual_start_medication	.
local:s43.1	local:AM-MNR	local:similarly	.
local:dual_antiplatelet	rdfs:subClassOf	local:antiplatelet	.
local:s11	rdf:predicate	local:assign	.
local:antiplatelet_therapy_use_cilostazol	rdfs:subClassOf	local:therapy_use_cilostazol	.
local:8_14	rdfs:subClassOf	local:14	.
local:s2.1	rdf:predicate	local:compare	.
local:stroke_recurrence	rdfs:subClassOf	local:recurrence	.
local:highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	rdfs:member	local:highrisk	.
local:dual_medication	rdfs:member	local:dual	.
local:safety_outcome_lifethreatening_bleed	rdfs:member	local:safety_outcome	.
local:determine_whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:differ_to_time	rdfs:member	local:differ	.
local:ischemic_stroke	rdfs:member	local:ischemic	.
local:longterm_dual_antiplatelet_therapy	rdfs:subClassOf	local:therapy	.
local:safety_outcome	rdfs:member	local:safety	.
local:accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:time	.
local:noncardioembolic_ischemic_stroke	rdfs:subClassOf	local:ischemic_stroke	.
local:s44	local:AM-MNR	local:similarly	.
local:s11	local:AM-MNR	local:randomly	.
local:patient_between_180_day_after_stroke_onset	rdfs:member	local:patient	.
local:differ_accord	rdfs:member	local:differ	.
local:patient_between_8_day_after_stroke_onset	rdfs:member	local:patient_between_8_day	.
local:s15	rdf:subject	local:patient_between_180_day_after_stroke_onset	.
local:accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:accord	.
local:alone_aspirin_after_highrisk_noncardioembolic_ischemic_stroke	rdfs:member	local:alone_aspirin	.
local:alone_aspirin_after_highrisk_noncardioembolic_ischemic_stroke_in_randomize_trial	rdfs:member	local:randomize_trial	.
local:medication_differ	rdfs:member	local:medication	.
local:subanalysis_of_patient_between_180_day	rdfs:member	local:subanalysis_of_patient	.
local:longterm_dual_antiplatelet_therapy_use_cilostazol	rdfs:subClassOf	local:cilostazol	.
local:safety_outcome	rdfs:subClassOf	local:outcome	.
local:s45	rdf:predicate	local:use	.
local:noncardioembolic_ischemic	rdfs:member	local:noncardioembolic	.
local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	rdfs:member	local:subanalysis	.
local:highrisk_noncardioembolic_ischemic_stroke_in_a_randomize_trial	rdfs:member	local:randomize_trial	.
local:subanalysis_of_patient_between_180_day_after_stroke_onset	rdfs:member	local:stroke_onset	.
local:highrisk_noncardioembolic_ischemic	rdfs:subClassOf	local:ischemic	.
local:180_day_group	rdfs:subClassOf	local:day_group	.
local:severe_bleed	rdfs:subClassOf	local:bleed	.
local:accord_to_the_time_of_start_trial_treatment	rdfs:member	local:accord	.
local:subanalysis_of_the_patient_between_8_day_after_stroke_onset	rdfs:member	local:day	.
local:s6	local:AM-MNR	local:randomly	.
local:stroke_recurrence_compare	rdfs:member	local:stroke_recurrence	.
local:noncardioembolic_ischemic_stroke	rdfs:subClassOf	local:stroke	.
local:lower_risk_of_stroke_recurrence_compare_to_clopidogrel_alone	rdfs:member	local:lower_risk	.
local:1879_498_patient	rdfs:subClassOf	local:498_patient	.
local:s34	rdf:predicate	local:belong	.
local:dual_antiplatelet	rdfs:member	local:dual	.
local:dual_antiplatelet_therapy	rdfs:subClassOf	local:antiplatelet_therapy	.
local:s16	rdf:subject	local:patient_between_8_day_after_stroke_onset	.
local:14_day_after_onset	rdfs:member	local:14_day	.
local:467_914	rdfs:subClassOf	local:914	.
local:alone_compare_to_aspirin	rdfs:member	local:alone_compare	.
local:s5.3	rdf:predicate	local:start	.
local:whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:effect	.
local:lower_risk_of_stroke_recurrence	rdfs:member	local:lower_risk	.
local:more_effective_for_secondary_stroke_prevention	rdfs:member	local:more_effective	.
local:randomize_trial	rdfs:subClassOf	local:trial	.
local:subanalysis_of_the_patient_between_180_day_after_stroke_onset	rdfs:member	local:patient	.
local:therapy_use	rdfs:subClassOf	local:use	.
local:determine_whether_the_effect_of_the_dual_medication_differ_accord_to_time_of_start_medication_after_stroke_onset	rdfs:member	local:dual_medication_differ_accord	.
local:hemorrhage_risk	rdfs:member	local:hemorrhage	.
local:longterm_treatment_with_the_combination_of_cilostazol_with_clopidogrel	rdfs:member	local:longterm_treatment	.
local:more_effective_for_secondary_stroke_prevention_than_monotherapy	rdfs:member	local:monotherapy	.
local:s4.1	rdf:object	local:risk_of_recurrent_ischemic_stroke	.
local:s44	rdf:predicate	local:occur	.
local:secondary_stroke_prevention	rdfs:subClassOf	local:stroke_prevention	.
local:stroke_prevention	rdfs:member	local:stroke	.
local:s45.2	rdf:object	local:therapy	.
local:dual_medication	rdfs:subClassOf	local:medication	.
local:s4	rdf:subject	local:dual_medication	.
local:s45.1	local:AM-TMP	local:15_to_180_day	.
